GLP-1 patches are based around transdermal deliverythe same method used in nicotine patches or hormonal contraceptives, where a substance passes through the skin and enters the bloodstream
The pathway for compounded GLP-1s has not closed entirely: legitimate patient-specific 503A compounding, with individualized clinical documentation, at the four-prescription safe harbor ceiling, remains legally available for genuine edge cases such as documented allergies to branded product excipients
After accounting for factors such as age, body weight, and existing health conditions, they found a modest increase in hair loss among GLP-1 users compared with the other two drug groups
PTD-DBM is a peptide specifically developed for hair growth that works through different mechanisms than copper peptides
As tirzepatide continues to be studied and used in broader populations, our understanding of its side effects will likely evolve